Skip to main content

Table 1 Weights, plasma lipids, and non-esterified fatty acids

From: Long-term probucol therapy continues to suppress markers of neurovascular inflammation in a dietary induced model of cerebral capillary dysfunction

  3 months 12 months
  LF SFA SFA + Probucol LF SFA SFA + Probucol
Weight (g) 22.2 ± 0.33 22.7 ± 0.33 22.7 ± 0.33 30.8 ± 1.5 36.4 ± 1.0 32.8 ± 2.5
Weight gain (g) - - - 14.3 ± 1.50 21.3 ± 1.02* 13.26 ± 2.53
Cholesterol (mmol/L) 3.18 ± 0.26 3.13 ± 0.22 0.58 ± 0.074** 3.25 ± 0.29 2.72 ± 0.12 0.58 ± 0.068**
Triglyceride (mmol/L) 0.35 ± 0.023 0.32 ± 0.038 0.44 ± 0.034 0.51 ± 0.082 0.45 ± 0.11 0.56 ± 0.13
NEFA (mEq/L) 0.49 ± 0.064 0.70 ± 0.041** 0.34 ± 0.041 0.47 ± 0.026 0.40 ± 0.021 0.44 ± 0.051
  1. LF = Low fat, SFA = Saturated fatty acid, NEFA = Non-esterified fatty acid.
  2. Data are shown as mean ± SEM. Statistical significance analyzed with one-way ANOVA followed by Tukey’s post hoc test (2 tailed, n = 8) is indicated at p < 0.05 (*) or at p < 0.01 (**).